On behalf of the organizing committee, we take this opportunity in extending a warm and cordial welcome to you to be a part of the Global Oncology and Cancer Summit. Global Oncology and Cancer Summit – 2020 conference is scheduled during 27th September, 2020, at Bangalore, India. This conference aim is to gather the most elegant societies and industries along with the renowned and honorable persons from top universities across the globe. The Global Oncology and Cancer Summit – 2020 organizing committee is confident that participants will get benefits from this high-value scientific program. We welcome all the researchers/ academicians join us at Bagalore, India.

About 12.7 million cancer cases and 7.6 million cancer deaths are estimated to have occurred in 2008 worldwide, with 56% of the cases and 64% of the deaths in the economically developing world. Breast cancer, the most common tumour in women, presents a high survival percentage: 83% of patients have survived this type of cancer after five years. Lung cancer is one of the most aggressive tumors and survival after five years is very low: only 10% of patients diagnosed with a malignant neoplasm survive for more than five years. Colorectal cancer (of the colon and rectum), the most common malignant tumour if we group men and women together, presents an average survival rate of 50-55% five years after diagnosis, meaning that half the patients survive this form of cancer. Prostate cancer, today the most common tumour in men, has an increasingly favourable prognosis, with a global survival rate of 76%, which is higher in young adults. Ovarian cancer presents a very varied prognosis depending on age: whilst 70% of the group between 15 and 44 years survives this form of cancer, this is the case for only 19% of those over 74 years-old.

The global cancer/tumor profiling market was valued at $13.30 billion in 2012. At the end of 2013, the market is estimated to be $14.99 billion and is poised to reach around $35 billion by 2018, growing at a CAGR of 18.50% from 2013 to 2018. Global oncology spending hit $91 billion for 2013 and it's growing at a 5% clip annually, which will cross $100 billion in 2015. The key players in the cancer/tumor profiling market are Boreal Genomics Inc. (U.S.), Caris Life Sciences (U.S.), Genomic Health Inc. (U.S.), Illumina Inc. (U.S.), Life Technologies Corporation (U.S.), NeoGenomics Laboratories (U.S.), Oxford Gene Technology Ltd. (U.K.), Precision Therapeutics Inc. (U.S.), bioTheranostics (U.S.), Proteome Sciences PLC (U.K.), Agendia (The Netherlands), Nanostring Technologies (U.S.), Rational Therapeutics (U.S.), Oncopath Laboratories (U.S.), and RiboMed BiotechnologiesInc. (U.S.). Global cancer diagnostics market is expected to reach $13.1 Billion in 2020 from an estimated $7.1 Billion in 2015, growing at a CAGR of 12.9%. The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). The cancer diagnostics market in Asia is expected to grow at the highest rate from 2015 to 2020. According to the market the global oncology drugs market is expected to reach at $111.9 billion by 2020. Patent expiration of key cancer drugs such as Herceptin, Erbitux, Rituxan and Avastin, is expected to boost the growth of cancer biosimilars market by 2020.

Global Oncology and Cancer Summit - 2020 is a one day event consisting of a lettered scientific program, laudable talks by the top notch of the global scientific community, that brings together active researchers, intellectuals, academicians, students, contributors and industrialists to exchange ideas communicate and discuss research findings on new advancements in all kinds of available oncology and cancer research worldwide innovative research products which can be exhibited for further development in Oncology. This Global Oncology and Cancer Summit – 2020 is going to be the largest and most promising international conference that specifically focuses on the Oncology, Radiation therapy by bringing all Renowned Oncologists under one roof. This will be the multidisciplinary meeting covering all aspects of Oncology, New Innovation, Cancer Drug Development, Cancer Therapies and Radiation Oncology, including clinical service delivery, management, informatics and research.

Similarly, the conference will show the students a new way for future innovations. The conference also focuses on current research evidence, practical experiences and innovative ideas on issues related to Oncology and Cancer Research

Looking forward to meet with you in Bangalore this Year.